Compound ID | 1308
ASN-4
Class: Antibody (monoclonal antibody [mAb])
| Spectrum of activity: | Gram-negative |
| Details of activity: | Bactericidal and anti-inflammatory activity against a clinical isolate carrying plasmid- encoded colistin resistance |
| Institute where first reported: | Arsanis Biosciences GmbH; United Arab Emirates University; |
| Year first mentioned: | 2017 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.